Jin Medical International
ZJYL on Nasdaq. Orthopedic, prosthetic & surgical appliances & supplies. Market value $294m.
This company reports once a year (it is based outside the US), so every figure comes from its annual report for the year to September 2025.
We can't read total debt from the filing, so debt is left out.
Should I look at this?
Not a fit for our list right now
Why it could be worth it
Nothing stands out yet.
See Health care stocks that passed both tests
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $-1.08 of spare cash last year. A savings account pays about $4.
The filings do not give us enough to work this out.
The filings do not give us enough to work this out.
Quality score: not known. Price score: 18 of 100. Our list needs 70 on quality and 60 on price.
$2.20 a share, 44% above its 1-year low
Over the past year the price has ranged from $1.53 to $8.48.
Pays no dividend
Prices from Monday’s close (2 November).
Five years of cash, in billions
| Revenue | |||
| Revenue | $20m | $24m | $21m |
| Operating margin | |||
| Operating margin | 14.5% | 15.5% | 2.9% |
| Debt to equity | |||
| Debt to equity | n/a | n/a | n/a |
| Shares outstanding | |||
| Shares outstanding | 0.16bn | 0.16bn | 0.16bn |
Health checks
- Free cash flow positive1 of 3 years
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)5 of 8 checks we could run
- Profit backed by cash (accruals)Yes
- DebtUnknown
- Revenue growth, five yearsUnknown
- Buying back its own sharesRoughly flat
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 10 February 2026
- Next quarterly (estimated, 10-Q)
- n/a
Who owns it
None of the long-term investors we follow own it. 4 funds in all.
Largest holders overall
- HRT Financial LP$28,000New
- Osaic Holdings$5,642
- UBS Group AG$1,767Cut
- Caitong International Asset Management$2New
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
2 investors own more than 5%.
- NOVASTRALIST HORIZON LTD.Passive investorat least 10.5%(filed with 1 related holder)Since 18 August 2026
- Erqi WangInsider or founderat least 3.4%−3.4 pts(filed with 1 related holder)Since 24 September 2026
What they said
The information set forth in Item 5 is hereby incorporated by reference into this Item 4. Item 4 is hereby amended and supplemented to add the following: This Amendment No. 1 is filed to report that the Reporting Persons' aggregate percentage beneficial ownership and voting…
Read the filing - Er Pu International LtdInsider or founderSold down below 5%Since 21 July 2026
What they said
The information set forth in or incorporated by reference into Item 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4. The transactions described in Item 3 were undertaken in connection with the Issuer's recapitalization and its…
Read the filing
| Holder | Stake | Since | |
|---|---|---|---|
NOVASTRALIST HORIZON LTD. Passive investor | at least 10.5% (filed with 1 related holder) | 18 August 2026 | |
Erqi Wang Insider or founder | at least 3.4%−3.4 pts (filed with 1 related holder) | 24 September 2026 | What they saidThe information set forth in Item 5 is hereby incorporated by reference into this Item 4. Item 4 is hereby amended and supplemented to add the following: This Amendment No. 1 is filed to report that the Reporting Persons' aggregate percentage beneficial ownership and voting… Read the filing |
Er Pu International Ltd Insider or founder | Sold down below 5% | 21 July 2026 | What they saidThe information set forth in or incorporated by reference into Item 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4. The transactions described in Item 3 were undertaken in connection with the Issuer's recapitalization and its… Read the filing |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
We have no insider filings for this company yet.
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
Jin Medical International doesn’t file a US annual report (10-K), so we haven’t checked it.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.